NCT05022914 PSMA Guided Approach for bIoCHEmical Relapse After Prostatectomy-PSICHE
| NCT ID | NCT05022914 |
| Status | Recruiting |
| Phase | — |
| Sponsor | Azienda Ospedaliero-Universitaria Careggi |
| Condition | Prostate Cancer |
| Study Type | OBSERVATIONAL |
| Enrollment | 180 participants |
| Start Date | 2021-01-19 |
| Primary Completion | 2024-01-19 |
Eligibility & Interventions
Eligibility Fast-Check
Enter your details for a quick preliminary check. This does not replace medical advice.
What to Expect as a Participant
This is an observational study. You will not receive an experimental treatment; researchers will collect data based on your existing condition or standard treatment.
This trial targets 180 participants in total. It began in 2021-01-19 with a primary completion date of 2024-01-19.
⚠ This information is for research awareness only. Always consult your physician before joining any clinical trial. Participation is voluntary and you may withdraw at any time.
Brief Summary
This observational study was designed to evaluate progression free survival after PSMA-PET/CT based salvage approach for patients affected by biochemical relapse after radical prostatectomy.
Eligibility Criteria
Inclusion Criteria: * Signed informed consent * Age \>18 * Patient suitable for 68Ga-PSMA PET/CT re-staging according to clinical practice (Previous radical prostatectomy with histological result of Prostate adenocarcinoma +/- postoperative prostate bed radiotherapy (adjuvant or salvage setting), with a biochemical relapse defined as a PSA \> 0.2 and \<1 Exclusion Criteria: * ADT administration within 6 months from study enrollment * Persistent elevation of PSA after RP measured within 16 weeks from surgery (\> 0.1 ng/ml)
Contact & Investigator
Lorenzo Livi, Prof.
PRINCIPAL INVESTIGATOR
Azienda Ospedaliero-Universitaria Careggi
Frequently Asked Questions
Who can join the NCT05022914 clinical trial?
This trial is open to male participants only, aged 18 Years or older, studying Prostate Cancer. Full inclusion and exclusion criteria are listed in the Eligibility Criteria section. Always confirm your eligibility with the research team before applying.
Is NCT05022914 currently recruiting?
Yes, NCT05022914 is actively recruiting participants. Contact the research team at lorenzo.livi@unifi.it for enrollment information.
Where is the NCT05022914 trial being conducted?
This trial is being conducted at Florence, Italy.
Who is sponsoring the NCT05022914 clinical trial?
NCT05022914 is sponsored by Azienda Ospedaliero-Universitaria Careggi. The principal investigator is Lorenzo Livi, Prof. at Azienda Ospedaliero-Universitaria Careggi. The trial plans to enroll 180 participants.
Related Trials
Related Intelligence Guides
In-depth guides covering this condition's trials, eligibility, and what to expect.